An introduction to AstraZeneca's new UK R&D Centre and Global Corporate Headquarters, which will be part of the Cambridge Biomedical Campus, to the south of the city. AstraZeneca's Dr. Briggs Morrison, EVP Global Medicines Development & Chief Medical Officer, Dr. Mene Pangalos, EVP Innovative Medicines & Early Development and Dr. Bahija Jallal, EVP, Head of MedImmune comment on the significance of the move. External stakeholder viewpoints from Dr. Keith McNeil, Chief Executive, Cambridge University Hospitals, NHS Foundation Trust; Rt Hon Andrew Lansley, CBE, MP, Leader of the House of Commons and Member of Parliament, South Cambridgeshire, UK; Dr. Robert Winter, Managing Director, Eastern Academic Health Science Network, UK and Jeanette Walker, Project Director, Liberty Property Trust & Countryside Properties.
